Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Sheyan Armaghani

Orthopaedic Surgery Lake Mary, FL Medical Doctor

NPI 1619294329 CMS profile 1324432

701 Platinum Pt, Lake Mary, FL 32746

Open in the dashboard

General payments

$85,003

147 records reported · program years 2019–2025

Research payments

$0

Paid to them · None reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Sheyan Armaghani of Lake Mary, FL is reported in the CMS Open Payments database as having received $85,003 across 147 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 92nd percentile of Orthopaedic Surgery profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

7 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $23,615 19
2024 General $25,051 31
2023 General $62 2
2022 General $3,819 13
2021 General $21,656 21
2020 General $4,959 15
2019 General $5,841 46

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Sheyan Armaghani
  • Orthopaedic Surgery median
  • Middle half of Orthopaedic Surgery
  • National median

In program year 2025, general payments to Sheyan Armaghani were reported at $23,615. Among 15,343 Orthopaedic Surgery profiles paid that year, the median was $563 and the middle half received between $147 and $2,717.

Show as a table
Year Sheyan Armaghani Orthopaedic Surgery median Middle half National median
2019 $5,841 $644 $140–$2,844 $163
2020 $4,959 $312 $75–$1,860 $114
2021 $21,656 $520 $117–$2,495 $132
2022 $3,819 $598 $128–$2,731 $149
2023 $62 $461 $128–$2,264 $160
2024 $25,051 $497 $134–$2,475 $164
2025 $23,615 $563 $147–$2,717 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Arthrex, Inc. $30,980 26 payments
  2. Stryker Corporation $28,879 46 payments
  3. Alphatec Spine, Inc $22,461 27 payments
  4. Zimmer Biomet Holdings, Inc. $930 11 payments
  5. Centinel Spine, LLC $376 5 payments
  6. Medtronic USA, Inc. $335 6 payments
  7. Medtronic, Inc. $322 9 payments
  8. NuVasive, Inc. $230 2 payments
  9. Fones Marketing Management, Inc. $148 5 payments
  10. Carlsmed, Inc. $104 1 payment
  11. Other $239 9 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $35,175 14 payments
  2. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $30,000 11 payments
  3. Travel and Lodging $13,740 31 payments
  4. Food and Beverage $6,088 91 payments
Products named General payments · program years 2019–2025
  1. Other - Miscellaneous $14,153 16 payments
  2. Battalion TLIF - PC $7,000 1 payment
  3. CASCADIA INTERBODY SYSTEM $6,375 1 payment
  4. NIAGARA LATERAL ACCESS SYSTEM $6,375 1 payment
  5. YUKON OCT SPINAL SYSTEM $4,820 5 payments
  6. STRYKER NAV3 $4,125 2 payments
  7. ALEUTIAN $4,025 2 payments
  8. XIA 3 $3,931 4 payments
  9. ALEUTIAN TLIF MI $1,750 1 payment
  10. TRITANIUM $1,570 3 payments
  11. Other $5,598 74 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 12 drugs

Part D claims

794

Median for Orthopedic Surgery: 203

Drug cost

$14,242

Median for Orthopedic Surgery: $1,433

Branded share of claims

2.9%

Median for Orthopedic Surgery: 11.6%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Celecoxib Generic 126 $9,534
Oxycodone Hcl Generic 197 $1,280
Methocarbamol Generic 102 $1,018
Gabapentin Generic 91 $753
Methylprednisolone Generic 50 $371
Tramadol Hcl Generic 82 $363
Ibuprofen Generic 16 $244
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 23 $235
Meloxicam Generic 57 $200
Cyclobenzaprine Hcl Generic 21 $121

The 10 drugs with the highest cost, of 12 counted.

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 18,934 Part D prescribers listed as Orthopedic Surgery; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 56 billing codes

Paid by Medicare

$228,011

Medicare's payments for the services billed

Medicare patients

498

Average age 73

Services billed

1,408

283 women, 215 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Arthritis 75%
Ischemic heart disease 44%
Diabetes 31%
Chronic kidney disease 27%
Depression 23%
Atrial fibrillation 20%
Osteoporosis 19%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

147 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Orthopaedic Surgery in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record